• Return to Headlines

Shares of Loxo Oncology In Rise Above Previous 52-Week High

By Amy Schwartz

Shares of Loxo Oncology In (NASDAQ:LOXO) traded today at $143.38, breaking its 52-week high. So far today approximately 55,000 shares have been exchanged, as compared to an average 30-day volume of 147,000 shares.

Loxo Oncology In (NASDAQ:LOXO) defies analysts with a current price ($143.22) 21.3% above its average consensus price target of $112.71. The stock should find initial support at its 50-day moving average (MA) of $23.30 and further support at its 200-day MA of $23.15.

Loxo Oncology, Inc. researches and develops cancer drugs. The company focuses on building small molecule cancer drugs for genetically defined patient subsets.

In the past 52 weeks, shares of Loxo Oncology In have traded between a low of $17.14 and a high of $143.38 and are now at $143.22, which is 736% above that low price. The 200-day and 50-day moving averages have moved 0.49% higher and 1.49% higher over the past week, respectively.

SmarTrend is monitoring the recent change of momentum in Loxo Oncology In. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Loxo Oncology In in search of a potential trend change.

Keywords: 52 week high/lows loxo oncology in

Ticker(s): LOXO